A phase I dose-ranging study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of AVN944, an IMPDH inhibitor, in healthy male volunteers (Q46275875)
Jump to navigation
Jump to search
scientific article published on 29 October 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase I dose-ranging study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of AVN944, an IMPDH inhibitor, in healthy male volunteers |
scientific article published on 29 October 2008 |
Statements
1 reference
A phase I dose-ranging study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of AVN944, an IMPDH inhibitor, in healthy male volunteers (English)
1 reference
J Michael Hamilton
1 reference
Matthew W Harding
1 reference
Thomas Genna
1 reference
David K Bol
1 reference
29 October 2008
1 reference
49
1 reference
1
1 reference
30-38
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference